240 related articles for article (PubMed ID: 28224273)
1. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
[TBL] [Abstract][Full Text] [Related]
2. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression.
Jang SJ; Choi IS; Park G; Moon DS; Choi JS; Nam MH; Yoon SY; Choi CH; Kang SH
Leuk Res; 2016 Aug; 47():172-7. PubMed ID: 27379838
[TBL] [Abstract][Full Text] [Related]
4. [Expression of miR-550a-5p in Myelodysplastic Syndrome and Its Prediction of Target Genes].
Huang Y; Wen J; Li HY; Zhang XP; Deng DH; Cheng P; Peng ZG; Zhao WH; Luo J; Long Y; Liu ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1476-1483. PubMed ID: 27784378
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-144 inhibits proliferation and promotes the apoptosis of myelodysplastic syndrome cells through the activation of the AKAP12-dependent ERK1/2 signaling pathway.
Qian W; Jin F; Zhao Y; Chen Y; Ge L; Liu L; Yang M
Cell Signal; 2020 Apr; 68():109493. PubMed ID: 31809872
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
7. Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Dostalova Merkerova M; Krejcik Z; Votavova H; Belickova M; Vasikova A; Cermak J
Eur J Hum Genet; 2011 Mar; 19(3):313-9. PubMed ID: 21150891
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes.
Choi JS; Nam MH; Yoon SY; Kang SH
Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V
Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221
[TBL] [Abstract][Full Text] [Related]
10. Hematopoiesis-related microRNA expression in myelodysplastic syndromes.
Pons A; Nomdedeu B; Navarro A; Gaya A; Gel B; Diaz T; Valera S; Rozman M; Belkaid M; Montserrat E; Monzo M
Leuk Lymphoma; 2009 Nov; 50(11):1854-9. PubMed ID: 19883312
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-597 in myelodysplastic syndromes induces apoptosis through FOSL2 inhibition.
Kang SH; Kim HB; Choi JS
Eur J Haematol; 2022 Dec; 109(6):680-685. PubMed ID: 36018564
[TBL] [Abstract][Full Text] [Related]
12. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes.
Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X
Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714
[TBL] [Abstract][Full Text] [Related]
13. miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes.
Kuang X; Wei C; Zhang T; Yang Z; Chi J; Wang L
Int J Oncol; 2016 Nov; 49(5):1921-1930. PubMed ID: 27633496
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
[TBL] [Abstract][Full Text] [Related]
15. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
Zhang S; Zhang Q; Shi G; Yin J
Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
[TBL] [Abstract][Full Text] [Related]
16. Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.
Kuang X; Chi J; Wang L
Hematology; 2016 Dec; 21(10):593-602. PubMed ID: 27357100
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.
Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH
Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200
[TBL] [Abstract][Full Text] [Related]
18. [Expression and Function of miR-99a-5p in Bone Marrow of Patients with MDS].
LE Y; Zhang XP; Xiong YQ; Li HY; Zhao WH; Long Y; Luo J; Cheng P; Liu ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):134-140. PubMed ID: 30738460
[TBL] [Abstract][Full Text] [Related]
19. Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia.
Kirimura S; Kurata M; Nakagawa Y; Onishi I; Abe-Suzuki S; Abe S; Yamamoto K; Kitagawa M
Pathology; 2016 Apr; 48(3):233-41. PubMed ID: 27020498
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.
Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS
Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
